Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Strategic Asset Allocation Index

Latest as of September 2023: 44.3%

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd strategic asset allocation index. Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has a Strategic Asset Allocation Index of 44.3% as of September 2023. Strategic assets (PP&E of CN¥1.03 Billion plus long-term investments of CN¥-) total CN¥1.03 Billion, measured against net assets of CN¥2.32 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how tangible is Tonghua Golden-Horse Pharmaceutical Indu's equity to evaluate the tangible quality of the company's equity base.

SAAI

44.3%
Strategic Assets / Net Assets

Strategic Assets

CN¥1.03 Billion
PP&E + LT Investments

PP&E

CN¥1.03 Billion
CNY

Net Assets

CN¥2.32 Billion
CNY

Strategic Asset Allocation Index of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (2000–2022)

Strategic asset allocation index of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 2000 to 2022. This chart shows how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of September 2023, the index stands at 44.3%, representing strategic assets of CN¥1.03 Billion against net assets of CN¥2.32 Billion CNY.

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Strategic Asset Allocation Index by Year (2000–2022)

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Tonghua Golden-Horse Pharmaceutical Indu worth.

Year SAAI Strategic Assets (CNY) PP&E LT Investments Net Assets Change (pp)
2022 44.4% CN¥1.05 Billion CN¥1.05 Billion CN¥- CN¥2.37 Billion ▼ -2.0 pp
2021 46.5% CN¥1.09 Billion CN¥1.09 Billion CN¥- CN¥2.34 Billion ▲ +2.9 pp
2020 43.6% CN¥1.00 Billion CN¥1.00 Billion CN¥- CN¥2.31 Billion ▲ +5.0 pp
2019 38.5% CN¥1.03 Billion CN¥1.03 Billion CN¥- CN¥2.67 Billion ▲ +16.3 pp
2018 22.2% CN¥1.05 Billion CN¥1.05 Billion CN¥- CN¥4.71 Billion ▼ -0.8 pp
2017 23.0% CN¥1.02 Billion CN¥1.02 Billion CN¥- CN¥4.42 Billion ▲ +0.2 pp
2016 22.8% CN¥948.40 Million CN¥948.40 Million CN¥- CN¥4.16 Billion ▼ -9.3 pp
2015 32.1% CN¥721.52 Million CN¥721.52 Million CN¥- CN¥2.25 Billion ▼ -33.4 pp
2014 65.5% CN¥431.86 Million CN¥431.86 Million CN¥- CN¥659.50 Million ▲ +18.6 pp
2013 46.9% CN¥288.55 Million CN¥288.55 Million CN¥- CN¥615.08 Million ▲ +26.4 pp
2012 20.5% CN¥126.92 Million CN¥126.92 Million CN¥- CN¥619.60 Million ▼ 0.0 pp
2011 20.5% CN¥124.48 Million CN¥124.48 Million CN¥- CN¥607.13 Million ▼ -26.6 pp
2010 47.1% CN¥280.61 Million CN¥280.61 Million CN¥- CN¥595.89 Million ▼ -3.3 pp
2009 50.4% CN¥294.39 Million CN¥294.39 Million CN¥- CN¥583.87 Million ▼ -3.2 pp
2008 53.7% CN¥297.30 Million CN¥297.30 Million CN¥- CN¥554.08 Million ▼ -3.0 pp
2007 56.6% CN¥303.95 Million CN¥303.95 Million CN¥- CN¥536.90 Million ▲ +24.9 pp
2006 31.7% CN¥164.08 Million CN¥164.08 Million CN¥- CN¥518.07 Million ▼ -377.3 pp
2005 408.9% CN¥185.08 Million CN¥185.08 Million CN¥- CN¥45.26 Million ▲ +8.2 pp
2004 400.8% CN¥146.83 Million CN¥146.83 Million CN¥- CN¥36.64 Million ▲ +315.2 pp
2003 85.6% CN¥253.29 Million CN¥253.29 Million CN¥- CN¥296.07 Million ▲ +48.7 pp
2002 36.8% CN¥180.70 Million CN¥180.70 Million CN¥- CN¥490.79 Million ▼ -0.8 pp
2001 37.6% CN¥178.56 Million CN¥178.56 Million CN¥- CN¥475.05 Million ▲ +16.7 pp
2000 20.9% CN¥225.41 Million CN¥225.41 Million CN¥- CN¥1.08 Billion —
pp = percentage points